Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recurrent hydrochlorothiazide-induced pulmonary edema

A Mas1, R Jordana, J Vallés

  • 1Intensive Care Service, Consorci Hospitalari Parc Taulí, Sabadell, Spain. arantxams@sumi.es

Intensive Care Medicine
|June 3, 1998
PubMed
Summary

Hydrochlorothiazide can cause a rare but dangerous reaction called pulmonary edema, leading to low oxygen and blood pressure. This idiosyncratic reaction requires prompt medical attention.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical presentation, diagnostic investigations, treatment protocols and outcomes of dogs diagnosed with tick-borne diseases living in the United Kingdom: 76 cases (2005-2019).

The Journal of small animal practice·2023
Same author

Clinical risk factors for early mortality in patients with community-acquired septic shock. The importance of adequate source control.

Medicina intensiva·2021
Same author

Summary of recommendations and key points of the consensus of Spanish scientific societies (SEPAR, SEMICYUC, SEMES; SECIP, SENEO, SEDAR, SENP) on the use of non-invasive ventilation and high-flow oxygen therapy with nasal cannulas in adult, pediatric, and neonatal patients with severe acute respiratory failure.

Medicina intensiva·2021
Same author

Summary of recommendations and key points of the consensus of Spanish scientific societies (SEPAR, SEMICYUC, SEMES; SECIP, SENEO, SEDAR, SENP) on the use of non-invasive ventilation and high-flow oxygen therapy with nasal cannulas in adult, pediatric, and neonatal patients with severe acute respiratory failure.

Medicina intensiva·2020
Same author

Clinical risk factors for early mortality in patients with community-acquired septic shock. The importance of adequate source control.

Medicina intensiva·2020
Same author

Polymerase Activity, Protein-Protein Interaction, and Cellular Localization of the Usutu Virus NS5 Protein.

Antimicrobial agents and chemotherapy·2019

Area of Science:

  • Pharmacology
  • Toxicology
  • Cardiopulmonary Medicine

Background:

  • Hydrochlorothiazide is a widely prescribed diuretic for hypertension and edema.
  • Adverse drug reactions can range from mild to life-threatening.
  • Pulmonary edema is a critical condition characterized by fluid accumulation in the lungs.

Observation:

  • Hydrochlorothiazide-induced pulmonary edema is an uncommon adverse event.
  • Clinical manifestations include hypoxemia, hypotension, and tachycardia.
  • Electrocardiographic and echocardiographic changes may also be present.

Findings:

  • The mechanism underlying this reaction is likely idiosyncratic, suggesting a non-dose-dependent, individual susceptibility.
  • Pulmonary edema presents as a severe, potentially fatal complication of hydrochlorothiazide use.

Related Experiment Videos

  • Associated symptoms highlight systemic effects beyond the respiratory system.
  • Implications:

    • Early recognition and discontinuation of hydrochlorothiazide are crucial for patient management.
    • Awareness among healthcare providers is essential to prevent misdiagnosis and delayed treatment.
    • Further research into the idiosyncratic mechanisms of drug-induced pulmonary edema is warranted.